| Dear Colleagues,
Please join the TRACE Bioethics Forum on Tuesday, September 15, 2026, for a live virtual discussion on Kenya’s experience reviewing, approving, and overseeing Controlled Human Infection Model (CHIM) studies.
CHIM studies are a specialized form of clinical research in which consenting healthy adult volunteers are exposed to a well-characterized pathogen under carefully controlled conditions and medical supervision. Because these studies raise distinctive questions about risk, informed consent, safety monitoring, participant protection, and continuing oversight, they require close coordination among investigators, ethics committees, regulatory authorities, and national research oversight bodies.
This 90-minute session will draw on Kenya’s practical experience with CHIM studies, including malaria and shigellosis research. Participants will hear perspectives from across the research oversight ecosystem and explore:
- The CHIM study approval landscape in Kenya
- Scientific and operational lessons from conducting CHIM research
- Ethics review, approval, and ongoing oversight considerations
- Regulatory and national research oversight responsibilities
- Opportunities for dialogue through live Q&A and chat-based discussion
Date: Tuesday, September 15, 2026 Time: 8:00 AM ET | 1:00 PM WAT | 2:00 PM CAT | 3:00 PM EAT Format: Live virtual session | 90 minutes
The TRACE Bioethics Forum supports peer learning, practical dialogue, and case-informed reflection on complex ethics issues in interventional clinical trials. Join the conversation and engage with colleagues on approaches to responsible CHIM study review and oversight.
Sincerely, MRCT Center |